Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency - PubMed (original) (raw)
Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency
R J Pomerantz et al. J Virol. 1992 Mar.
Abstract
The Rev protein of human immunodeficiency virus type 1 (HIV-1) is essential for the expression of the structural genes of HIV-1. To determine whether a functional threshold level of Rev is required to allow efficient HIV-1 replication, CD4-positive HeLa cells, constitutively expressing a Rev-deficient provirus, were transfected with various quantities of a Rev-expressing plasmid. Compared with the quantity of the Rev-producing plasmid transfected, HIV-1 replication was distinctly nonlinear as measured by HIV-1 p24 antigen and HIV-1-specific RNA production. A quantitative RNA polymerase chain reaction (PCR) demonstrated that Rev mRNA expression was linearly correlated with the quantity of Rev-expressing plasmid which was transfected into these cells. These data suggest that a critical threshold of Rev is required for a highly productive HIV-1 infection. This threshold level of Rev may be involved in the generation and maintenance of HIV-1 proviral latency.
Similar articles
- Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
Bevec D, Dobrovnik M, Hauber J, Böhnlein E. Bevec D, et al. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9870-4. doi: 10.1073/pnas.89.20.9870. Proc Natl Acad Sci U S A. 1992. PMID: 1409715 Free PMC article. - Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.
Arrigo SJ, Weitsman S, Rosenblatt JD, Chen IS. Arrigo SJ, et al. J Virol. 1989 Nov;63(11):4875-81. doi: 10.1128/JVI.63.11.4875-4881.1989. J Virol. 1989. PMID: 2677405 Free PMC article. - Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW, Gallardo HF, Gilboa E, Smith C. Lee SW, et al. J Virol. 1994 Dec;68(12):8254-64. doi: 10.1128/JVI.68.12.8254-8264.1994. J Virol. 1994. PMID: 7966618 Free PMC article. - The human immunodeficiency virus type 1 Rev protein: a pivotal protein in the viral life cycle.
Hope T, Pomerantz RJ. Hope T, et al. Curr Top Microbiol Immunol. 1995;193:91-105. doi: 10.1007/978-3-642-78929-8_5. Curr Top Microbiol Immunol. 1995. PMID: 7648880 Review. No abstract available. - Inhibition of HIV-1 replication by targeting the Rev protein.
Nakaya T, Iwai S, Fujinaga K, Otsuka E, Ikuta K. Nakaya T, et al. Leukemia. 1997 Apr;11 Suppl 3:134-7. Leukemia. 1997. PMID: 9209321 Review.
Cited by
- Retroviral hijacking of host transport pathways for genome nuclear export.
Behrens RT, Sherer NM. Behrens RT, et al. mBio. 2023 Dec 19;14(6):e0007023. doi: 10.1128/mbio.00070-23. Epub 2023 Nov 1. mBio. 2023. PMID: 37909783 Free PMC article. Review. - HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.
Crespo R, Rao S, Mahmoudi T. Crespo R, et al. Front Cell Infect Microbiol. 2022 Jun 14;12:855092. doi: 10.3389/fcimb.2022.855092. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35774399 Free PMC article. Review. - Novel assays to investigate the mechanisms of latent infection with HIV-2.
Lu MD, Telwatte S, Kumar N, Ferreira F, Martin HA, Kadiyala GN, Wedrychowski A, Moron-Lopez S, Chen TH, Goecker EA, Coombs RW, Lu CM, Wong JK, Tsibris A, Yukl SA. Lu MD, et al. PLoS One. 2022 Apr 27;17(4):e0267402. doi: 10.1371/journal.pone.0267402. eCollection 2022. PLoS One. 2022. PMID: 35476802 Free PMC article. - Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.
Jackson PEH, Dzhivhuho G, Rekosh D, Hammarskjold ML. Jackson PEH, et al. Curr HIV Res. 2020;18(2):85-98. doi: 10.2174/1570162X18666200106112842. Curr HIV Res. 2020. PMID: 31906839 Free PMC article. - Barriers for HIV Cure: The Latent Reservoir.
Castro-Gonzalez S, Colomer-Lluch M, Serra-Moreno R. Castro-Gonzalez S, et al. AIDS Res Hum Retroviruses. 2018 Sep;34(9):739-759. doi: 10.1089/AID.2018.0118. Epub 2018 Aug 28. AIDS Res Hum Retroviruses. 2018. PMID: 30056745 Free PMC article. Review.
References
- Cell. 1989 Dec 1;59(5):789-95 - PubMed
- Anal Biochem. 1976 May 7;72:248-54 - PubMed
- J Virol. 1989 Nov;63(11):4875-81 - PubMed
- J Virol. 1988 Jul;62(7):2291-9 - PubMed
- Nature. 1986 May 22-28;321(6068):412-7 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials